For PCI patients, prasugrel stands out as the best oral P2Y12 inhibitor, associated with a lower likelihood of MACE, MI, and stent thrombosis without an increase in major bleeding, based on a new meta-analysis. www.tctmd.com/news/meta-an...
www.tctmd.com
Compared with clopidogrel, the drug comes with better efficacy and less risk of major bleeding than ticagrelor.
